Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
This page offers a quick comparison of Index Fund and Target Date for retirement, with tips on matching your plans and risk tolerance.
24,517 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Pi Network's Core Team rolled out a major redesign of the mining app and Pioneer profile page, promising clearer navi...
Medicare open enrollment months are fast approaching. This guide lays out three practical moves you can make now to r...
As AI partnerships captivate the market, UiPath shares edged higher amid broader tech weakness. This look at stock ma...
As AI spending shifts from hype to heavy borrowing, Goldman Sachs warns AI's debt tsunami may tighten credit markets....
Amazon is emerging as an undervalued winner in the AI hyperscaler war, backed by a 30 percent price-performance edge ...
A booming demand backdrop for chips collides with sky-high spending. This piece breaks down what Taiwan Semiconductor...
In a striking contrast, Nancy Pelosi buys bullish calls on Amazon as Berkshire Hathaway scales back its Amazon exposu...
New reports say Lagarde is weighing an earlier departure, which could derail the ECB's digital euro plan and MiCA rol...
Palantir’s stock dropped third from its peak as investor Michael Burry reveals a new critique centered on the company...
Coinbase tees up investor attention with a marquee Super Bowl ad ahead of its February earnings, while crypto M&A exp...
Discover how Claros Mortgage Trust CMTG generates income, navigates rate risk, and positions its portfolio for the ne...